Format

Send to

Choose Destination
Am J Kidney Dis. 2015 Jul;66(1):172-3. doi: 10.1053/j.ajkd.2015.04.010.

Discontinuation of eculizumab treatment in atypical hemolytic uremic syndrome: an update.

Author information

1
Center for HUS Control, Prevention and Management, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Electronic address: ardissino@centroseu.org.
2
Center for HUS Control, Prevention and Management, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
PMID:
26111906
DOI:
10.1053/j.ajkd.2015.04.010
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center